Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Beijing's ChosenMed Partners with Integrated DNA of the US on Cancer Diagnostics

publication date: Jun 28, 2019

ChosenMed Technology, a Beijing medical sequencing company, has formed a strategic cooperation with Iowa's Integrated DNA Technologies to develop pan-cancer diagnostic panels as part of the Cancer Genome Atlas of China (CGAC) project. The project's major goal is to standardize cancer diagnoses in China. It is also using cancer sequencing to develop personalized medicine and transformative healthcare in China. IDT will provide NGS enrichment products to ChosenMed along with its scientific research and development capabilities. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital